Press What’s news at AbelsonTaylor Group
Select category
								
							Top Innovations of 2024: AT Activate
Established in 2012, PM360 introduced the first-ever issue focused entirely on the pharma and healthcare marketing industry’s latest innovations. In 2024, AbelsonTaylor Group’s AT Activate was selected as a leader in Marketing Technology or Services. AT Activate, a full-service media agency, offers advanced end-to-end media strategy capabilities that make high-impact pharmaceutical advertising accessible to brands of all sizes. The solution is transforming the pharmaceutical advertising landscape for clients by leveraging data-driven insights, advanced technologies, and a dynamic approach to consumer, patient and healthcare professional (HCP) engagement. This strategy democratizes DTC high-cost TV buys with digital streaming for smaller brands or rare disease conditions with modest budgets. Read more at https://www.pm360online.com/pm360-2024-innovative-marketing-technology-or-services-at-activate/
Media Contact:
Recent Posts
What Pharma Can Teach Every Marketer About Risk, Regulation and Trust
What happens when regulation, trust, and creativity collide in healthcare marketing? In his latest guest post for the 4A’s and...
In the News Read more What Pharma Can Teach Every Marketer About Risk, Regulation and TrustElsa Varghese, M.D., Joins AbelsonTaylor Group as Medical Strategy Director
CHICAGO – October 16, 2025 — AbelsonTaylor Group, a leading independent healthcare marketing and communications agency, is pleased to announce...
Read Press Read more Elsa Varghese, M.D., Joins AbelsonTaylor Group as Medical Strategy DirectorThe case for independent agencies
As mergers continue to reshape the advertising industry, AbelsonTaylor Group President Jeff Berg shares his perspective with MM+M on the...
In the News Read more The case for independent agenciesConnect with us
Find out what's top of mind for the people reimagining health and wellness advertising.